VC-4468
Business of BeautyProduct dossier
Shiseido Sells Chinese Aupres Producer to IDG Capital Consortium
Shiseido is selling Shiseido Liyuan Cosmetics, maker of the Aupres brand sold in China, to an investor consortium led by IDG Capital. Terms were not disclosed.
Counter notes
- Shiseido is selling subsidiary Shiseido Liyuan Cosmetics to an IDG Capital-led consortium; financial terms undisclosed.
- SLC was founded in 1991 and has made Aupres skin care for the Chinese market since 1994.
- SLC's capital was 94 million renminbi ($14.1 million) by end-2025.
- The joint venture agreement with Beijing Liyan was expiring in December 2026; Shiseido bought out its 35 percent stake beforehand.
- Shiseido will license some IP and provide product development, technical and supply support for a set transition period.
Shiseido Co. Ltd. is selling Shiseido Liyuan Cosmetics Co. Ltd., its Chinese subsidiary that manufactures the Aupres skin care brand, to a consortium of investors led by IDG Capital. Financial terms were not disclosed.
The consortium includes two special purpose vehicles founded by funds managed by IDG and an external management partnership, Shiseido said. The deal transfers equity interest in SLC, a consolidated subsidiary, along with the Beijing factory and its production equipment.
"China is a strategically important market for Shiseido and an attractive, dynamic market where the competitive landscape continues to evolve amid the rapid expansion of e-commerce, changing consumer behavior and the emergence of diverse market participants," the group said in a statement. "Shiseido views these changes as opportunities for growth and seeks to drive sustainable growth and strengthen its competitiveness in China by focusing management resources on areas where it enjoys the greatest competitive advantage."
What is Shiseido selling?
SLC dates to 1991, founded as a joint venture between Shiseido and Beijing Liyan Co. Ltd., a subsidiary of Yiquing Group, which was owned by the Beijing Municipal Government. Since 1994, SLC has manufactured and marketed Aupres skin care, which is sold in China. By the end of 2025, SLC's capital stood at 94 million renminbi, or $14.1 million.
The joint venture agreement between Shiseido and Beijing Liyan was set to expire in December 2026. In the run-up to that date, Shiseido acquired the 35 percent equity interest in SLC held by Beijing Liyan, giving it full ownership ahead of the sale.
Why sell now?
Shiseido framed the exit as a question of investment priorities. "To achieve sustainable growth for SLC, continued investment in product innovation and digital capabilities is essential in light of evolving market and competitive dynamics," the company said. "Following a comprehensive evaluation of the business sustainability and investment priorities, Shiseido concluded that transferring the business, including the Beijing Factory of SLC and its production equipment, to IDG would best support SLC's future development and serve the interest of its stakeholders."
To support the handover, Shiseido is granting licenses for some intellectual property rights. For a set period after the transfer, the group will also provide ongoing support on product development, technical assistance and supply of raw materials and selected products.
What does this change for Shiseido in China?
The company keeps its China and Travel Retail businesses. It says it will allocate resources toward nurturing focus brands, strengthening its brand portfolio, advancing R&D, expanding into new growth areas and leveraging digital and AI capabilities.
"In China and the Travel Retail business, the group will continue to drive sustainable growth and enhance its competitiveness by strategically allocating management resources," Shiseido said.
The divestment closes a chapter that began with a Beijing government-linked partnership in 1991 and shifts Aupres production to local private-equity ownership. It signals that Shiseido now prefers to deploy capital in China behind brands, research and digital capability rather than owned manufacturing infrastructure.
via WWD (Source)
More from Daniel Okafor
Show full bio
News editor covering money, funding and market shifts around skincare, haircare, makeup, fragrance, nails at Eurasian Beauty Journal.
133 articles